Research indicates that irisin may significantly impact the modulation of COVID-19-related genes, resulting in a decrease in genes associated with increased viral infection and an increase in genes that block angiotensin-converting enzyme 2 receptor activity [17,18]. This evidence concerns the gene FNDC5 and COVID-19.